Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Renal safety of short-term empiric gentamicin therapy in aged patients

Sia CS, Ananda-Rajah MR, Adler NR, Yi-Wei B, Liew D, Tong EY, Aung AK

(2018), Australas J Ageing, 37(3), 227-223

DOI: 10.1111/ajag.12541

Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting

Aung AK, Tang MJ, Adler NR, de Menezes SL, Goh MSY, Tee HW, Trubiano JA, Puy R, Zubrinich CM, Graudins LV

(2018), J Clin Pharmacol, 58(10), 1332-1339

DOI: 10.1002/jcph.1148

Medication-related anaphylaxis treated in hospital: Agents implicated, patient outcomes, and management lessons

Graudins LV, Trubiano JA, Zubrinich CM, Elliott AS, Aung AK

(2018), PHARMACOEPIDEM DR S, 27(9), 1029-1033

DOI: 10.1002/pds.4587

A case of multi-drug resistant ESBL-producing Shigella sonnei acute acalculous cholecystitis and gastroenteritis in a returned traveller

Williams E, Lew TE, Fuller A, Spelman DW, Jenney AW

(2018), J Travel Med, 25(1)

DOI: 10.1093/jtm/tay029

Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy

Beckman K, O'Callaghan M, Vincent A, Roder D, Millar J, Evans S, McNeil J, Moretti K

(2018), ANZ J Surg, 88(3), e183-188

DOI: 10.1111/ans.13954

Mycobacterium abscessus complex: Natural history and treatment outcomes at a tertiary adult cystic fibrosis center

Tippett E, Ellis S, Wilson J, Kotsimbos T, Spelman D

(2018), Int J Mycobacteriol, 7(2), 109-116

DOI: 10.4103/ijmy.ijmy_55_18

Mathematical modelling of vancomycin-resistant enterococci transmission during passive surveillance and active surveillance with contact isolation highlights the need to identify and address the source of acquisition

Cheah ALY, Cheng AC, Spelman D, Nation RL, Kong DCM, McBryde ES

(2018), BMC Infect Dis, 18(1), 511

DOI: 10.1186/s12879-018-3388-y

Initial modelling and updates on cost effectiveness from the first 10 years of a spleen registry

Luu S, Jones P, Woolley I, Spelman D, Gold L

(2018), Aust N Z J Public Health, 42(5), 463-466

DOI: 10.1111/1753-6405.12832

A Registry for Patients With Asplenia/Hyposplenism Reduces the Risk of Infections With Encapsulated Organisms

Arnott A, Jones P, Franklin LJ, Spelman D, Leder K, Cheng AC

(2018), Clin Infect Dis, 67(4), 557-561

DOI: 10.1093/cid/ciy141

Management of neurosyphilis: time for a new approach?

Smibert OC, Jenney AWJ, Spelman DW

(2018), Intern Med J, 48(2), 204-206

DOI: 10.1111/imj.13703

Incidence and outcomes of catheter related thrombosis (CRT) in patients with acute leukemia using a platelet-adjusted low molecular weight heparin regimen

Htun KT, Ma MJY, Lee AYY

(2018), J Thromb Thrombolysis, 46(3), 386-392

DOI: 10.1007/s11239-018-1711-5

Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma

Chee A, Low MS, Vilcassim S, Gregory GP, Gilbertson M, Ratnasingam S, Grigoriadis G, Fedele PL

(2018), Br J Haematol, 182(5), 739-741

DOI: 10.1111/bjh.14871

DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma

Yuen HLA, Low MSY, Fedele P, Kalff A, Walker P, Bergin K, Coutsouvelis J, Grigoriadis G, Spencer A

(2018), Leuk Lymphoma, 59(12), 2842-2846

DOI: 10.1080/10428194.2018.1454595

Concentrating non-dilute urine before protein electrophoresis for the detection of monoclonal free light chains is unnecessary and wasteful

Haran H, Choy KW, Wijeratne N, Tudball R, Doery J, Grigoriadis G, Lu Z

(2018), Pathology, 50(5), 587-588

DOI: 10.1016/j.pathol.2018.02.004

IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos

Fedele PL, Willis SN, Liao Y, Low MS, Rautela J, Segal DH, Gong JN, Huntington ND, Shi W, Huang DCS, Grigoriadis G, Tellier J, Nutt SL

(2018), Blood, 132(20), 2166-2178

DOI: 10.1182/blood-2018-05-850727

High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia

Marquis M, Beaubois C, Lavall»e VP, Abrahamowicz M, Danieli C, Lemieux S, Ahmad I, Wei A, Ting SB, Fleming S, Schwarer A, Grimwade D, Grey W, Hills RK, Vyas P, Russell N, Sauvageau G, H»bert J

(2018), Blood Cancer J, 8(8), 68

DOI: 10.1038/s41408-018-0103-6

Australian multicentre study of current real-world prophylaxis practice in severe and moderate haemophilia A and B

Mason JA, Parikh S, Tran H, Rowell J, McRae S

(2018), Haemophilia, 24(2), 253-260

DOI: 10.1111/hae.13375

Principles of haemophilia care: The Asia-Pacific perspective

Dunkley S, Lam JCM, John MJ, Wong RSM, Tran H, Yang R, Nair SC, Shima M, Street A, Srivastava A; Asia-Pacific Haemophilia Working Group (APHWG)

(2018), Haemophilia, 24(3), 366-375

DOI: 10.1111/hae.13425

Principles of haemophilia care: The asia pacific perspective. Response

Dunkley S, Lam JCM, John MJ, Wong RSM, Tran H, Yang R, Nair SC, Shima M, Street A, Srivastava A

(2018), Haemophilia, 24(4), e243-4

DOI: 10.1111/hae.13522

Update on diagnosis and anticoagulant therapy for venous thromboembolism

Stevens H, Tran H

(2018), Intern Med J, 48(10), 1175-1184

DOI: 10.1111/imj.14063

331 332 333 334 335